3 Matching Annotations
  1. Oct 2026
    1. F2.II.1

      Case#: 17 year old male

      Disease: Glazmann's Thrombasthenia Like Syndrome

      CasePresentingHPOs: HP:0032438, HP:0001873 PLT anisocytosis, Thrombocytopenia

      CaseNotHPOs: HP:0001892

      Abnormal Bleeding

      FamilyInfo: Pedigree figure 1. Mother, affected, had significant bleeding abnormalities, brother also affected with frequent epistaxis but PLT normal counts

      PlateletAgreggation: Decreased PLT aggregation and diminished ATP release with the agonists ADP, collagen, and AA. Ristocetin not assessed in individual per supplementary table

      GenotypingMethod: genetic analysis of ITGA2B and ITGB3 genes was performed by next-generation sequencing (NGS). Sanger sequencing used to confirm variants.

      ClinVar: 50233

      CAID: CA10575573

      Variant: NM_000419.5:c.3076C>T

      GnomAD: Not Found

      ExpressionEvidence: Level of expression on PLT surface determined by FCM: CD41a (GPIIb/IIIa) 45%, CD61 (GPIIIa) 46%, and CD42b (GPIb) 111%. Healthy control value range: CD41a (GPIIb/IIIa) (85-115%); CD61 (GPIIIa) (80-120%); CD42b (GPIb) (70-130%).

    2. Patient F3.II.1

      Case#: 64 year old male

      Disease: Glazmann's Thrombasthenia Like Syndrome

      CasePresentingHPOs: HP:0001873, HP:0000421

      Thrombocytopenia, Epistaxis

      CaseNotHPOs: HP:0006298

      Prolonged bleeding after dental extractions

      FamilyInfo: Pedigree figure 1. Mother, affected, thrombocytopenia, son, affected, thrombocytopenia. Daughter normal PLT.

      PlateletAgreggation: Decreased PLT aggregation and diminished ATP release with the agonists ADP, collagen, and AA, with normal ristocetin agglutination

      GenotypingMethod: genetic analysis of ITGA2B and ITGB3 genes was performed by next-generation sequencing (NGS). Sanger sequencing used to confirm variants.

      ClinVar: 50233

      CAID: CA10575573

      Variant: NM_000419.5:c.3076C>T

      GnomAD: Not Found

      ExpressionEvidence: Level of expression on PLT surface determined by FCM: CD41a (GPIIb/IIIa) 37%, CD61 (GPIIIa) 40%, and CD42b (GPIb) 82%. Healthy control value range: CD41a (GPIIb/IIIa) (85-115%); CD61 (GPIIIa) (80-120%); CD42b (GPIb) (70-130%).

    3. F1.III.4

      Case#: 26 year old female

      Disease: Glazmann's Thrombasthenia Like Syndrome

      CasePresentingHPOs: HP:0000978, HP:0001873

      Bruising susceptibility, Thrombocytopenia,

      CaseNotHPOs: HP:0004846

      FamilyInfo: Three sisters all with thrombocytopenia and easy bruising/nose bleeding during infancy. Mother and grandmother had identical phenotype. Disease segregation with thrombocytopenia and decreased GPIIb/IIIa in the affected patients was confirmed. Pedigree figure 1.

      PlateletAgreggation: Famiy member studied: Decreased PLT aggregation and diminished ATP release with the agonists ADP, collagen, and AA, Ristocetin not assessed in individual per supplementary table.

      GenotypingMethod: genetic analysis of ITGA2B and ITGB3 genes was performed by next-generation sequencing (NGS). Sanger sequencing used to confirm variants.

      ClinVar: 50233

      CAID: CA10575573

      Variant: NM_000419.5:c.3076C>T

      GnomAD: Not Found

      ExpressionEvidence: Level of expression on PLT surface determined by FCM: CD41a (GPIIb/IIIa) 45%, CD61 (GPIIIa) 56%, and CD42b (GPIb) 155%. Healthy control value range: CD41a (GPIIb/IIIa) (85-115%); CD61 (GPIIIa) (80-120%); CD42b (GPIb) (70-130%).